Listen to this article
Estimated 3 minutes
The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results.
A new medical research facility in Winnipeg will play a critical role in closing gaps in Canadian vaccine research and other areas of public health emergency preparedness, officials said Wednesday.
The new $267-million medical countermeasures lab, to be built at the rear of the federal National Microbiology Lab on Arlington Street, will produce experimental vaccines and other research to respond to future pandemics.
Federal and provincial politicians, along with medical researchers, announced the awarding of a $10.2-million contract to design firm Architecture49 at a Wednesday news conference at the microbiology lab.
The expected completion date is sometime in 2033, Winnipeg South member of Parliament Terry Duguid said.
“This is a big deal,” said Duguid. “This is a big deal for our city, our province, a big deal for life sciences in Canada to help protect the nation and the world,” he said.
In addition to its medical research, the facility will spur employment through construction and technical support work, enable scientists’ careers and also possibly lure private industry to move to the city to be in proximity to the lab’s services, media were told at the morning news conference.
It will be owned and operated by the federal government.
The practical gap that the lab will ultimately fill is developing high-quality test vaccines and therapeutics that will advance for further testing, said Keith Fowke, medical director of the Institute of Infection and Immunity.
It will not be a large-scale manufacturing facility, said Fowke.
“It will produce the test lots that are required … and then you narrow down which of your products are most effective” before mass manufacturing takes place, Fowke said.
The new lab’s proximity to the high-security Winnipeg microbiology lab — currently the only lab in Canada that can study the world’s most dangerous pathogens, which have no known vaccines or treatments — makes sense, as it will build on existing know-how, Fowke suggested.
“The expertise the NML has is going to be instrumental in being able to run and operate those facilities,” said Fowke.
The new lab will include Level 2 and Level 3-rated facilities, while the microbiology lab is rated Level 4 — the highest level of containment.
Architecture49 won the contract through an open bid process that unfolded after the government issued a request for proposals, officials said. The company, which maintains an office on Buffalo Place in Winnipeg, has a history of being tapped for similar work.
On its website, it lists numerous past projects such as the Life Sciences Research Institute in Halifax and the Rocky Mountain Integrated Research Facility in Montana.
